Every 15 hours another New Yorker dies waiting for a life-saving organ transplant. It doesn’t have to be this way. Sign up to be an organ donor today.http://www.HateTheWait.org
For more information visit:
http://www.liveonny.org/
Last Updated on January 25, 2020 by HepFree NYC
New York state’s Medicaid program spent $193.2 million during the first six months of 2014 on Sovaldi, the controversial Hepatitis C drug that carries an $84,000-per-patient price tag.
Each year the President of the United States acknowledges World Hepatitis Day and states urgency to prevent, diagnose, and treat this disease.
The NYC Health Department today released the City's first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS
To build community and provider partnerships for prevention, raise awareness, provide screening, immunization and referral services, and reduce cultural and language barriers for treatment for liver diseases for African immigrants and refugees.
FDA Expands Daklinza/Sovaldi Approval to Include Treatment of Hep C Genotype 1
Participants described psychological and behavioral transformation over the course of HCV treatment. These included reductions in internalized stigma and shame related to HCV and addiction, increases in HCV disclosure and self-care, reductions in substance use, and new desire to ...
Evaluation of whether enrollment in Project INSPIRE was associated with differences in HCV treatment and cure compared with a demographically similar group not enrolled in the programme.
The US Preventative Screening Task Force (USPSTF) has begun the process for developing HBV screening recommendations.
